Astigmatism Correction Through Excimer Laser Ablation Profiles: A Descriptive Review and Guide
- PMID: 40778872
- DOI: 10.3928/1081597X-20250617-01
Astigmatism Correction Through Excimer Laser Ablation Profiles: A Descriptive Review and Guide
Abstract
Purpose: To review the reported outcomes for correction of astigmatism using excimer laser-based corneal refractive surgery techniques and to present distinctly the intricacies of the different ablation profiles.
Methods: Keywords such as "refractive correction," "excimer lasers," "ablation profiles," and "astigmatism" were used for literature research. Inclusion criteria were strict relevance and adequacy to the clinical questions under research, and availability of the abstract in the English language.
Results: Bitoric, cross-cylinder, and custom wavefront-optimized (aberration-neutral) or wavefront-guided treatments are used in modern laser systems to correct astigmatism. From scientific literature reviewed in this article, laser ablation to correct astigmatism was found to produce satisfactory visual outcomes in terms of safety, efficacy, and predictability. Custom ablation respecting postoperative corneal curvature gradient, correcting true corneal astigmatism after eliminating the higher order aberrations, and accurately compensating for possible cyclotorsion will result in patient satisfaction.
Conclusions: Integrating subjective and objective assessment of astigmatism effectively to optimize treatment outcomes is complex, particularly across a wide range of refractive errors. Properly determining how much astigmatism should be incorporated into the treatment is critical. Ignoring ocular residual astigmatism and sculpting the cornea based only on manifest refraction has the penalty that the entire ocular residual astigmatism remains as postoperative surgical residual astigmatism, also resulting in induction of spherical aberrations. Centration, optical zone sizes, cyclotorsion compensation, and use of appropriate treatment algorithms are of prime importance in obtaining favorable outcomes in correction of astigmatism.
Conflict of interest statement
Disclosure: SA-M and SV are employees of SCHWIND eye-tech-solutions GmbH.
Similar articles
-
Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia.Cochrane Database Syst Rev. 2014 Jun 17;2014(6):CD007679. doi: 10.1002/14651858.CD007679.pub4. Cochrane Database Syst Rev. 2014. PMID: 24937100 Free PMC article.
-
Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia.Cochrane Database Syst Rev. 2012 Jan 18;1:CD007679. doi: 10.1002/14651858.CD007679.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Jun 17;(6):CD007679. doi: 10.1002/14651858.CD007679.pub4. PMID: 22258972 Updated.
-
Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia.Cochrane Database Syst Rev. 2010 May 12;(5):CD007679. doi: 10.1002/14651858.CD007679.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2012 Jan 18;1:CD007679. doi: 10.1002/14651858.CD007679.pub3. PMID: 20464757 Updated.
-
Safety and Effectiveness of Laser in Situ Keratomileusis Using the Teneo 317 Model 2 for Correcting Myopia and Myopic Astigmatism: Results of the U.S. FDA Clinical Trial.J Refract Surg. 2024 Aug;40(8):e544-e553. doi: 10.3928/1081597X-20240611-03. Epub 2024 Aug 1. J Refract Surg. 2024. PMID: 39120020 Clinical Trial.
-
Clinical Evaluation of the Stationary Scanning-Spot EX500 Excimer Laser System for Hyperopic LASIK in Patients With Hyperopia With and Without Astigmatism.J Refract Surg. 2025 Jul;41(7):e655-e661. doi: 10.3928/1081597X-20250520-04. Epub 2025 Jul 1. J Refract Surg. 2025. PMID: 40626427 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources